If the hypothesis of an equivalence of effect in both age groups proves to be true, not only in the first year of therapy but also in the long term after discontinuation of treatment, this could lead to greater acceptance of these only causal forms of treatment for IgE-mediated allergy. The gene discussed is IGHE; the disease is Allergy.